← back to search

Thomas Vanhove

Utrecht University · NL
Area of research
Transplantation · Pediatrics, Perinatology and Child Health
Research interest
Research interests include Medicine, Calcineurin, Tacrolimus, Transplantation, Pharmacology, and CYP3A4.
h-index
citations
742
works
9
NIH funding
primary concept
email

Recent publications

Histological characteristics of Acute Tubular Injury during Delayed Graft Function predict renal function after renal transplantation
Physiological Reports 2019cited by 45position: middledoi
Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients
American Journal of Transplantation 2017cited by 87position: firstdoi
Clinical determinants of calcineurin inhibitor disposition: a mechanistic review
Drug Metabolism Reviews 2016cited by 169position: firstdoi
High Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal Recipients
American Journal of Transplantation 2016cited by 132position: firstdoi
Kidney Fibrosis
Transplantation 2016cited by 90position: firstdoi
Drug–drug interactions between immunosuppressants and antidiabetic drugs in the treatment of post-transplant diabetes mellitus
Transplantation Reviews 2016cited by 52position: firstdoi
Effect of the Direct Oral Anticoagulants Rivaroxaban and Apixaban on the Disposition of Calcineurin Inhibitors in Transplant Recipients
Therapeutic Drug Monitoring 2016cited by 45position: firstdoi
Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit
British Journal of Clinical Pharmacology 2015cited by 56position: middledoi
Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcome
Transplant International 2013cited by 66position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Dirk Kuypers · Utrecht University9 papers (2013–2019)Pieter Annaert · KU Leuven4 papers (2016–2017)Roel Goldschmeding · Utrecht University2 papers (2016–2019)Robin Vos · KU Leuven2 papers (2016–2017)Isabel Spriet · Pharmac2 papers (2016–2017)Sandrine Florquin · Nationwide Children's Hospital1 papers (2019–2019)Tobias T. Pieters · Utrecht University1 papers (2019–2019) · 1 papers (2017–2017)Kristin Verbeke · KU Leuven1 papers (2015–2015)Maarten B. Rookmaaker · Utrecht University1 papers (2019–2019)Tom Vermeulen · KU Leuven1 papers (2016–2016)Bart Vanaudenaerde · KU Leuven1 papers (2017–2017)Evelyne Lerut · KU Leuven1 papers (2016–2016)Jesse J. Swen · Centre for Human Drug Research1 papers (2017–2017)Hylke de Jonge · KU Leuven1 papers (2015–2015)Marianne C. Verhaar · University of Applied Sciences Utrecht1 papers (2019–2019)Lucas L. Falke · Utrecht University1 papers (2019–2019)Geert M. Verleden · Antwerp University Hospital1 papers (2017–2017)Tri Q. Nguyen · Virginia Commonwealth University1 papers (2019–2019)Pieter Gillard · BioCryst Pharmaceuticals (United States)1 papers (2016–2016)